Director of Microbiology and Infectious Diseases Molecular Diagnostics at University of Louisville Hospital
BIOGRAPHY
Speakers
-
Aparna Ahuja, MD
Chief Medical Officer, T2 BiosystemsBIOGRAPHY -
Denise Uettwiller-Geiger, PhD, DLM (ASCP)
Clinical Transformation Liaison and Clinical Chemist,Mather HospitalBIOGRAPHY
Event Date & Time
Date: March 16, 2022
Time: 07:00am (PDT), 10:00am (EDT), 4:00pm (CEDT)
Abstract
During this webinar, we will provide an overview of the current landscape of sepsis management and the impact of rapid culture-independent diagnostics on healthcare systems. We will present the best practices for implementing T2 sepsis panels based on first-hand experience at the University of Louisville Hospital. We will also review how implementing T2 sepsis panels can impact laboratory workflow and patient outcomes. Speakers will discuss “Choosing Wisely”, a framework encompassing diagnostic stewardship to drive practice changes that will improve the quality of care for patients suspected of sepsis, while also optimizing healthcare resources.
Learning Objectives
- Compare culture-independent testing versus current diagnostic methods and the implications on healthcare outcomes, antimicrobial stewardship.
- Review a successful experience of implementing T2 Biosystems' diagnostics in the hospital laboratory and the positive impact on operational and clinical outcomes.
- Outline how utilizing the “Choosing Wisely” framework tool can better match diagnostics with specific patient needs and populations for more effective care. Examine the clinical indicators that predict a high value outcome by ordering T2 Biosystems Panels and how to implement changes to your practice.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...